Optimized New Shengmai Powder suppresses ferroptosis in ischemic cardiomyocytes via cGMP-PKG signalling.

In contrast, LY294002 treatment—whether administered alone or in combination with ONSMP—resulted in COX2 expression that was not only significantly higher than in the ONSMP group but also showed an increasing trend compared with the OGD group (Fig. 5 A).

also in 63,971 other papers